2-105363443-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001318895.3(FHL2):c.530G>A(p.Arg177Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00252 in 1,611,134 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001318895.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHL2 | NM_001318895.3 | c.530G>A | p.Arg177Gln | missense_variant | 6/7 | ENST00000530340.6 | NP_001305824.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHL2 | ENST00000530340.6 | c.530G>A | p.Arg177Gln | missense_variant | 6/7 | 1 | NM_001318895.3 | ENSP00000433567.2 |
Frequencies
GnomAD3 genomes AF: 0.0135 AC: 2049AN: 152156Hom.: 42 Cov.: 32
GnomAD3 exomes AF: 0.00352 AC: 856AN: 243348Hom.: 20 AF XY: 0.00254 AC XY: 334AN XY: 131448
GnomAD4 exome AF: 0.00138 AC: 2008AN: 1458860Hom.: 45 Cov.: 32 AF XY: 0.00121 AC XY: 876AN XY: 725396
GnomAD4 genome AF: 0.0135 AC: 2054AN: 152274Hom.: 42 Cov.: 32 AF XY: 0.0131 AC XY: 977AN XY: 74456
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 24, 2012 | Arg177Gln in exon 5 of FHL2: This variant is classified as benign based on its h igh frequency in the general population (dbSNP rs113188481). - |
Cardiomyopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Apr 05, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Primary dilated cardiomyopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at